WA
WestEnd Advisors Portfolio holdings
AUM
$4.03B
This Quarter Return
+0.1%
1 Year Return
+16.84%
3 Year Return
+52.53%
5 Year Return
+81.57%
10 Year Return
+163.89%
AUM
$3.93B
AUM Growth
-$148M
(-3.6%)
Cap. Flow
-$92.6M
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
66.65%
Holding
411
New
12
Increased
117
Reduced
62
Closed
69
Top Buys
| 1 |
Financial Select Sector SPDR Fund
XLF
|
$86.8M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
$53M |
| 3 |
iShares Expanded Tech-Software Sector ETF
IGV
|
$51.8M |
| 4 |
Chubb
CB
|
$43.8M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
$35.5M |
Top Sells
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$101M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
$92.6M |
| 3 |
Real Estate Select Sector SPDR Fund
XLRE
|
$44M |
| 4 |
Duke Energy
DUK
|
$41.8M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$35M |
Sector Composition
| 1 | Technology | 5.45% |
| 2 | Financials | 4.78% |
| 3 | Healthcare | 3.66% |
| 4 | Communication Services | 2.8% |
| 5 | Consumer Discretionary | 2.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
KKR & Co
KKR
$120B
| $2.07K | ﹤0.01% |
14
+1
| +8% | +$148 |
|
102
Pfizer
PFE
$141B
| $1.99K | ﹤0.01% |
75
+11
| +17% | +$292 |
|
103
Danaher
DHR
$143B
| $1.84K | ﹤0.01% |
8
+1
| +14% | +$230 |
|
104
Amgen
AMGN
$153B
| $1.82K | ﹤0.01% |
7
+1
| +17% | +$261 |
|
105
Stryker
SYK
$149B
| $1.8K | ﹤0.01% |
5
+1
| +25% | +$360 |
|
106
Intercontinental Exchange
ICE
$100B
| $1.79K | ﹤0.01% |
12
+1
| +9% | +$149 |
|
107
American Express
AXP
$225B
| $1.78K | ﹤0.01% |
6
+2
| +50% | +$594 |
|
108
Boston Scientific
BSX
$159B
| $1.7K | ﹤0.01% |
19
+2
| +12% | +$179 |
|
109
Oracle
ORCL
$628B
| $1.67K | ﹤0.01% |
10
+2
| +25% | +$333 |
|
110
CME Group
CME
$97.1B
| $1.63K | ﹤0.01% |
7
| – | – |
|
111
Bristol-Myers Squibb
BMY
$96.7B
| $1.53K | ﹤0.01% |
27
+4
| +17% | +$226 |
|
112
Gilead Sciences
GILD
$140B
| $1.48K | ﹤0.01% |
16
+2
| +14% | +$185 |
|
113
Walt Disney
DIS
$211B
| $1.45K | ﹤0.01% |
13
-1
| -7% | -$111 |
|
114
Progressive
PGR
$145B
| $1.44K | ﹤0.01% |
6
+2
| +50% | +$479 |
|
115
Moody's
MCO
$89B
| $1.42K | ﹤0.01% |
3
| – | – |
|
116
Citigroup
C
$175B
| $1.34K | ﹤0.01% |
19
+4
| +27% | +$281 |
|
117
Adobe
ADBE
$148B
| $1.33K | ﹤0.01% |
3
+1
| +50% | +$445 |
|
118
Intuit
INTU
$187B
| $1.26K | ﹤0.01% |
2
+1
| +100% | +$629 |
|
119
Vertex Pharmaceuticals
VRTX
$102B
| $1.21K | ﹤0.01% |
3
| – | – |
|
120
AT&T
T
$208B
| $1.21K | ﹤0.01% |
53
-1
| -2% | -$23 |
|
121
MSCI
MSCI
$42.7B
| $1.2K | ﹤0.01% |
2
+1
| +100% | +$600 |
|
122
McDonald's
MCD
$226B
| $1.16K | ﹤0.01% |
4
-1
| -20% | -$290 |
|
123
Verizon
VZ
$184B
| $1.16K | ﹤0.01% |
29
-3
| -9% | -$120 |
|
124
Bank of New York Mellon
BK
$73.8B
| $1.15K | ﹤0.01% |
15
+1
| +7% | +$77 |
|
125
McKesson
MCK
$85.9B
| $1.14K | ﹤0.01% |
2
+1
| +100% | +$570 |
|